The board of directors of Kintor Pharmaceutical Limited announces that Dr. Bing Chen ("Dr. Chen") has resigned as a non-executive Director and a member of the audit committee of the Company (the "Audit Committee") with effect from 30 April 2021 due to pursuit of his personal commitments. The Board further announces that Dr. Yan Wang ("Dr. Wang") has been appointed by the Board as a non-executive Director and a member of the Audit Committee with effect from 30 April 2021. Dr. Wang, aged 32, has joined Highlight Capital since December 2020 as Vice President. He was a senior investment manager at TF Capital from September 2019 to December 2020. He was a senior manager at WuXi Biologics Co. Ltd. of project management from October 2017 to August 2019. Prior to that, he was a research fellow at Nanyang Technological University of Singapore.